Role of Acute Graft-Versus-Host Disease in the Risk of Bacteremia and Invasive Fungal Disease after Allogeneic Hemopoietic Stem Cell Transplantation in Children. Results from a Single-Center Observational Study

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 7, 2014, Pages 1068-1073

  Castagnola, Elio ^a   Bagnasco, Francesca ^a   Bandettini, Roberto ^a   Caviglia, Ilaria ^a   Morreale, Giuseppe ^a   Lanino, Edoardo ^a   Giardino, Stefano ^a   Moroni, Cristina ^a   Haupt, Riccardo ^a   Faraci, Maura ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Acute graft versus host disease; Allogeneic hemopoietic stem cell transplantation; Bacteremia; Children; Invasive fungal disease

Indexed keywords

AMOXICILLIN; CYCLOSPORIN; METHOTREXATE; METHYLPREDNISOLONE; SULTAMICILLIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SYSTEMIC MYCOSIS; ACUTE DISEASE; ADVERSE EFFECTS; ALLOTRANSPLANTATION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; INCIDENCE; MICROBIOLOGY; MYCOSIS; PRESCHOOL CHILD;

ACUTE DISEASE; BACTEREMIA; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MYCOSES; RISK FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 84902118802     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.03.026     Document Type: Article

References (25)

1. Castagnola E., Bagnasco F., Faraci M., et al. Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: a single center experience. Bone Marrow Transplant 2007, 41:339-347.
2. Castagnola E., Faraci M., Moroni C., et al. Bacteremias in children receiving hemopoietic SCT. Bone Marrow Transplant 2008, 41:S104-S106.
3. Castagnola E., Faraci M., Moroni C., et al. Invasive mycoses in children receiving hemopoietic SCT. Bone Marrow Transplant 2008, 41:S107-S111.
4. Wingard J.R., Hsu J., Hiemenz J.W. Hematopoietic stem cell transplantation: an overview of infection risk and epidemiology. Infect Dis Clin North Am 2011, 25:101-116.
5. Faraci M., Lanino E., Morreale G., et al. Bacteremias and invasive fungal diseases in children receiving etanercept for steroid-resistant acute GVHD. Bone Marrow Transplant 2010, 46:159-160.
6. De Pauw B., Walsh T.J., Donnelly J.P., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
7. Faraci M., Caviglia I., Biral E., et al. Acute graft-versus-host disease in pediatric allogeneic hematopoietic stem cell transplantation. Single center experience during 10 yr. Pediatr Transplantation 2012, 16:887-893.
8. Martin P.J., Rizzo J.D., Wingard J.R., et al. First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2012, 18:1150-1163.
9. Kelly P.J., Lim L.L. Survival analysis for recurrent event data: an application to childhood infectious diseases. Stat Med 2000, 19:13-33.
10. Fine J.P., Gray R.J. A proportional hazards model for the subdistribution of competing risk. J Am Stat Assoc 1999, 94:496-509.
11. Lili L., Wang J., Zhang W., et al. Risk factors for invasive mold infections following allogeneic hematopoietic stem cell transplantation: a single center study of 190 recipients. Scand J Infect Dis 2012, 44:100-107.
12. Teixeira Mendes E., Dulley F., Basso M., et al. Healthcare-associated infection in hematopoietic stem cell transplantation patients: risk factors and impact on outcome. Int J Infect Dis 2012, 16:e424-e428.
13. Martinho G.E., Romanelli R.M.C., Teixeira G.M., et al. Infectious complications associated with the use of central venous catheters in patients undergoing hematopoietic stem cell transplantation. Am J Infect Control 2013, 41:642-644.
14. Poutsiaka D.D., Munson D., Price L.L., et al. Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated. Bone Marrow Transplant 2011, 46:300-307.
15. Marr K.A., Carter R.A., Boeckh M., et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002, 100:4358-4366.
16. Frere P., Baron F., Bonnet C., et al. Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen. Bone Marrow Transplant 2006, 37:411-418.
17. McQuay H.J., Moore R.A. Using numerical results from systematic reviews in clinical practice. Ann Intern Med 1997, 126:712-720.
18. Castagnola E., Fontana V., Caviglia I., et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis 2007, 45:1296-1304.
19. Hamza N.S., Lisgaris M., Yadavalli G., et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol 2004, 124:488-498.
20. Garcia-Vidal C., Upton A., Kirby K.A., Marr K.A. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis 2008, 47:1041-1050.
21. Benjamin D.K., Miller W.C., Bayliff S., et al. Infections diagnosed in the first year after pediatric stem cell transplantation. Pediatr Infect Dis J 2002, 21:227-234.
22. Hale K.A., Shaw P.J., Dalla-Pozza L., et al. Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant. Br J Haematol 2010, 149:263-272.
23. Pagano L., Akova M., Dimopoulos G., et al. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother 2011, 66(Suppl 1):i5-i14.
24. Camps I.R. Risk factors for invasive fungal infections in haematopoietic stem cell transplantation. Int J Antimicrob Agents 2008, 32(Suppl 2):S119-S123.
25. Romano V., Castagnola E., Dallorso S., et al. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation. Bone Marrow Transplant 1999, 23:271-275.